Report me for selling fake medicine? Why are you crying when your illness relapses?

She knew that Antai Pharmaceutical Group was very valuable and had promising future development prospects. If she wanted to acquire Antai Pharmaceutical Group now, she would definitely have to pay a premium.

She was mentally prepared for this.

But she still didn't expect that Chen Xuan would ask for 3000 billion US dollars right away, and this is the current price.

If you don't acquire it now, it will be $4000 billion in a month, and $5000 billion in another month.

In short, it increased by $1000 billion in one month.

Anna was so shocked by the price that she was speechless.

Even if it is a premium acquisition, it shouldn't be so exaggerated. This is too inconsistent with market rules.

However, this interview did change many of her ideas, and all her plans also changed quietly.

"At $3000 billion, it seems the acquisition is out of the question."

"AbbVie, Johnson & Johnson, and Mosadone have been hyped for so long, I wonder what they are feeling now."

After thinking about this, Anna couldn't help laughing again.

When Chen Xuan said that the patent for the lung cancer drug was worth $1000 billion, she had already given up the idea of ​​acquiring it.

Whether it was the patent for a special lung cancer drug or Antai Real Estate Group, she knew it was impossible for her to acquire it.

After all, Chen Xuan is really not short of money, and Antai Pharmaceutical Group is not short of money either. In addition, with the official support of China, they are even less short of money.

In this case, there is no hope of acquiring it unless a high premium is offered.

Especially when he said that he wanted to acquire a special drug for lung cancer and that he would need to prepare $1000 billion, she knew that there was no hope.

Not to mention acquiring Antai Pharmaceutical Group, even if he wanted to acquire shares, he couldn't do it. He had no shortage of funds and no idea of ​​raising funds.

So, Anna not only gave up herself, but also asked the Novartis board of directors to give up the idea, telling them not to think about it anymore and that it was a waste of time.

Later, news suddenly broke that the three giants, Johnson & Johnson, Mosadone, and AbbVie, would join forces to acquire Aetna Pharmaceuticals Group.

This suddenly made Anna feel a little interesting, and she also watched the matter.

The outside world doesn't know whether it's true or not, but she is quite clear about this matter.

The rumors are both true and false, and they were deliberately spread by three pharmaceutical giants: Johnson & Johnson, AbbVie, and Mosadone.

The purpose of the dissemination was to push up the stock prices of the three giants, and in fact it was successful. The news of the acquisition of Antai Pharmaceutical Group caused the stock prices of the three giants to rise significantly.

The market is indeed very optimistic about Antai Pharmaceutical Group and believes that whoever acquires Antai Pharmaceutical Group will have a bright future.

This news has made pharmaceutical giants such as Novartis quite nervous.

Anna is worried that after the previous pharmaceutical giant acquires Antai Pharmaceutical Group, it will form a monopoly trend in the pharmaceutical industry, its competitiveness will become stronger, and the situation of other competitors will become more difficult.

Novartis, in particular, could have been the agent for Aetna Pharmaceuticals Group's drugs and had an exclusive overseas agency contract.

But if it is acquired by the three pharmaceutical giants, Novartis will lose the agency contract and will no longer be able to represent Aetna Pharmaceutical Group's drugs.

Moreover, once the three companies join forces to acquire the company, they will surely become close allies in the future.

The strength of any of the three companies is terrifying, and now that they are united together, they are even more powerful than giants.

Because of this, this news has caused anxiety in the entire industry, and many pharmaceutical giants are holding meetings overnight, including Novartis.

Anna has been very busy with this matter these days.

But now, after hearing that Chen Xuan's offer was 3000 billion US dollars, Anna felt relieved instantly.

It is basically impossible for the three pharmaceutical giants, Mosadone, Johnson & Johnson, and AbbVie, to agree to the price of US$3000 billion.